CIR
Pharmaceutical preparations, in particular in the form of protein, nucleic acid, or cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections; living cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections; biological preparations in the form of protein, nucleic acid, or...
Pending · July 17, 2023 · 98088355 ·